UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 34

Sortiert nach

Fungal burden, dimorphic transition and candidalysin: Role in Candida albicans-induced vaginal cell damage and mitochondrial activation in vitro

PloS one, 2024-05, Vol.19 (5), p.e0303449-e0303449

2024

Volltextzugriff (PDF)

Lactobacillus acidophilus, L. plantarum, L. rhamnosus, and L. reuteri Cell-Free Supernatants Inhibit Candida parapsilosis Pathogenic Potential upon Infection of Vaginal Epithelial Cells Monolayer and in a Transwell Coculture System In Vitro

Microbiology spectrum, 2022-06, Vol.10 (3), p.e0269621-e0269621

2022

Volltextzugriff (PDF)

A New Phenotype in Candida -Epithelial Cell Interaction Distinguishes Colonization- versus Vulvovaginal Candidiasis-Associated Strains

mBio, 2023-04, Vol.14 (2), p.e0010723-e0010723

2023

Volltextzugriff (PDF)

Trastuzumab emtansine is active on HER-2 overexpressing NSCLC cell lines and overcomes gefitinib resistance

Molecular cancer, 2014-06, Vol.13 (1), p.143-143, Article 143

2014

Volltextzugriff (PDF)

Combined use of anti-ErbB monoclonal antibodies and erlotinib enhances antibody-dependent cellular cytotoxicity of wild-type erlotinib-sensitive NSCLC cell lines

Molecular cancer, 2012-12, Vol.11 (1), p.91-91, Article 91

2012

Volltextzugriff (PDF)

Human Epidermal Growth Factor Receptor 2 Status and Interval Breast Cancer in a Population-Based Cancer Registry Study

Journal of clinical oncology, 2012-07, Vol.30 (19), p.2362-2368

2012

Volltextzugriff (PDF)

Molecular Mechanisms Underlying the Antitumor Activity of 3-Aminopropanamide Irreversible Inhibitors of the Epidermal Growth Factor Receptor in Non–Small Cell Lung Cancer

Neoplasia (New York, N.Y.), 2013, Vol.15 (1), p.61-IN18

2013

Volltextzugriff (PDF)

Skin Toxicities with Cyclin-Dependent Kinase 4/6 Inhibitors in Breast Cancer: Signals from Disproportionality Analysis of the FDA Adverse Event Reporting System

American journal of clinical dermatology, 2022-03, Vol.23 (2), p.247-255

2022

Volltextzugriff (PDF)

Effective retreatment with osimertinib in CNS-relapsed epidermal growth factor receptor-mutant non-small cell lung cancer patient following resection and adjuvant osimertinib

Anti-cancer drugs, 2024-01, Vol.35 (1), p.86

2024

Volltextzugriff (PDF)

Should We Test Cancer Susceptibility Genes in Routinely Used Multigene Panels? A Case of Synchronous Lung Adenocarcinoma and Breast Cancer Associated With Germline CHEK2 Mutation

Clinical lung cancer, 2022-06, Vol.23 (4), p.e283-e284

2022

Volltextzugriff (PDF)

Multifactorial Central Nervous System Recurrence Susceptibility in Patients With HER2-Positive Breast Cancer: Epidemiological and Clinical Data From a Population-Based Cancer Registry Study

Cancer, 2011-05, Vol.117 (9), p.1837-1846

2011

Volltextzugriff (PDF)

The pathogenic and colonization potential of Candida africana

Microbes and infection, 2024-01, Vol.26 (1-2), p.105230, Article 105230

2024

Volltextzugriff (PDF)

Gefitinib and afatinib treatment in an advanced non-small cell lung cancer (NSCLC) patient undergoing hemodialysis

Anticancer research, 2014-06, Vol.34 (6), p.3185-3188

2014

Volltextzugriff (PDF)

Colony-stimulating factors for febrile neutropenia

The New England journal of medicine, 2013-07, Vol.369 (3), p.285

2013

Volltextzugriff (PDF)

Response to Osimertinib in Choroidal Metastases from EGFRmt T790M–Positive Non–Small Cell Lung Adenocarcinoma

Journal of thoracic oncology, 2017-10, Vol.12 (10), p.e165-e167

2017

Volltextzugriff (PDF)

BOLERO-3 results: pharmacological activity or pharmacokinetic effect?

The lancet oncology, 2014-07, Vol.15 (8), p.e304-e304

2014

Volltextzugriff (PDF)

Overcoming Primary Resistance to PD-1 Inhibitor With Anti–PD-L1 Agent in Squamous-Cell NSCLC: Case Report

Clinical lung cancer, 2020-03, Vol.21 (2), p.e45-e48

2020

Volltextzugriff (PDF)

Efficacy and safety of long-term tolvaptan treatment in a patient with SCLC and SIADH

Tumori, 2015-03, Vol.101 (2), p.e51-e53

2015

Volltextzugriff (PDF)

Different clinical effects upon separate inhibition of coexisting EGFR and PI3KCA mutations in a lung adenocarcinoma patient

Lung cancer (Amsterdam, Netherlands), 2015-02, Vol.87 (2), p.204-206

2015

Volltextzugriff (PDF)

Overcoming T790M-driven acquired resistance to EGFR-TKIs in NSCLC with afatinib: a case report

Tumori, 2014-01, Vol.100 (1), p.e20-e23

2014

Volltextzugriff (PDF)

BRCA mutations, molecular markers, and clinical variables in early-onset breast cancer: A population-based study

Breast (Edinburgh), 2007-06, Vol.16 (3), p.280-292

2007

Volltextzugriff (PDF)

Colony-Stimulating Factors for Febrile Neutropenia

The New England journal of medicine, 2013, Vol.369 (3), p.284-286

2013

Volltextzugriff (PDF)

Colony-stimulating factors for febrile neutropenia

The New England journal of medicine, 2013-07, Vol.369 (3), p.286-286

2013

Volltextzugriff (PDF)

Endometrial metastasis of lung adenocarcinoma: A case report

Tumori, 2011-05, Vol.97 (3), p.411-414

2011

Volltextzugriff (PDF)

Detection of follicular fluid and serum antibodies by protein microarrays in women undergoing in vitro fertilization treatment

Journal of reproductive immunology, 2011-04, Vol.89 (1), p.62-69

2011

Volltextzugriff (PDF)

1 – 25 von 34

Suche als RSS-Feed

Aktive Filter

ThemaMale

ThemaFemale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(34)
Mit Volltextzugriff
(31)

Publikationsform

Artikel
(34)

Sprache

Englisch
(34)
Japanisch
(4)

Erscheinungsjahr

n.n

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Fungal burden, dimorphic transition and candidalysin: Role in Candida albicans-induced vaginal cell damage and mitochondrial activation in vitro

Lactobacillus acidophilus, L. plantarum, L. rhamnosus, and L. reuteri Cell-Free Supernatants Inhibit Candida parapsilosis Pathogenic Potential upon Infection of Vaginal Epithelial Cells Monolayer and in a Transwell Coculture System In Vitro

A New Phenotype in Candida -Epithelial Cell Interaction Distinguishes Colonization- versus Vulvovaginal Candidiasis-Associated Strains

Trastuzumab emtansine is active on HER-2 overexpressing NSCLC cell lines and overcomes gefitinib resistance

Combined use of anti-ErbB monoclonal antibodies and erlotinib enhances antibody-dependent cellular cytotoxicity of wild-type erlotinib-sensitive NSCLC cell lines

Human Epidermal Growth Factor Receptor 2 Status and Interval Breast Cancer in a Population-Based Cancer Registry Study

Molecular Mechanisms Underlying the Antitumor Activity of 3-Aminopropanamide Irreversible Inhibitors of the Epidermal Growth Factor Receptor in Non–Small Cell Lung Cancer

Skin Toxicities with Cyclin-Dependent Kinase 4/6 Inhibitors in Breast Cancer: Signals from Disproportionality Analysis of the FDA Adverse Event Reporting System

Effective retreatment with osimertinib in CNS-relapsed epidermal growth factor receptor-mutant non-small cell lung cancer patient following resection and adjuvant osimertinib

Should We Test Cancer Susceptibility Genes in Routinely Used Multigene Panels? A Case of Synchronous Lung Adenocarcinoma and Breast Cancer Associated With Germline CHEK2 Mutation

Multifactorial Central Nervous System Recurrence Susceptibility in Patients With HER2-Positive Breast Cancer: Epidemiological and Clinical Data From a Population-Based Cancer Registry Study

The pathogenic and colonization potential of Candida africana

Gefitinib and afatinib treatment in an advanced non-small cell lung cancer (NSCLC) patient undergoing hemodialysis

Colony-stimulating factors for febrile neutropenia

Response to Osimertinib in Choroidal Metastases from EGFRmt T790M–Positive Non–Small Cell Lung Adenocarcinoma

BOLERO-3 results: pharmacological activity or pharmacokinetic effect?

Overcoming Primary Resistance to PD-1 Inhibitor With Anti–PD-L1 Agent in Squamous-Cell NSCLC: Case Report

Efficacy and safety of long-term tolvaptan treatment in a patient with SCLC and SIADH

Different clinical effects upon separate inhibition of coexisting EGFR and PI3KCA mutations in a lung adenocarcinoma patient

Overcoming T790M-driven acquired resistance to EGFR-TKIs in NSCLC with afatinib: a case report

BRCA mutations, molecular markers, and clinical variables in early-onset breast cancer: A population-based study

Colony-Stimulating Factors for Febrile Neutropenia

Colony-stimulating factors for febrile neutropenia

Endometrial metastasis of lung adenocarcinoma: A case report

Detection of follicular fluid and serum antibodies by protein microarrays in women undergoing in vitro fertilization treatment

Aktive Filter

Suchergebnisse filtern